INBIOMOTION

Inbiomotion is a Barcelona-based personalized medicine company incorporated in 2010 with the goal of developing biomarkers that predict bone metastasis to improve the quality of life of cancer patients... Inbiomotion is a Science driven company founded in 2010 based on de novo discovery of MAF gene as effective biomarker for bone metastasis. We are a spin-out of IRB Barcelona and ICREA research labs, VC-backed, founded by scientists to combine clinical and technology innovation for the benefit of patients in precision medicine... Founded in 2010 by Prof. Roger Gomis, Inbiomotion is a spin-off of IRB Barcelona and ICREA research institutions.

Primary location: Barcelona Spain